Africa UN Knowledge Hub for COVID-19

With promising results from three major COVID-19 vaccine trials and potentially more to come, it’s becoming clear that access to coronavirus vaccines will soon become reality. But despite unprecedented global pushes to ensure access for low- and middle-income countries, the majority of available vaccine doses have been earmarked for wealthy countries that have the political and financial capital to make direct agreements with pharmaceutical companies.